Stem cell research.
Any day now we should get the verdict from the judge in the big stem cell clinic case here in California against Cell Surgical Network, et al. It seems that the FDA is waiting on this verdict before taking some major actions. If the judge rules against the agency it could throw the area into […]
Weekly stem cell reads: pending FDA verdict, blood vessels, RA Read More »
Liveyon is a cord blood product marketer that distributed a batch of cells a couple of years back that led to many patients being hospitalized with infections. Some had sepsis and ended up in the ICU. It was thought at the time that about a dozen patients who had been injected with the Liveyon product
Liveyon product hurt many more patients says new CDC study Read More »
As many of you know I am a cancer survivor myself so studying cancer stem cells has meaning for me on another level. Cancer is also the possible side effect most patients worry about when considering going to an unproven stem cell clinic. I’ve got a new video up on possible stem cell side effects
Weekly reads: cancer stem cells, Bik, & more Read More »
Last week we lost Meri Firpo, a great scientist and dear friend in the stem cell community who touched many lives in positive ways. Today’s post is a tribute to Meri, who passed away from breast cancer. If you want to add a tribute please add a comment. Meri Firpo short bio Meri received her
Tribute to pioneering stem cell scientist Meri Firpo Read More »
The stem cell field lost a great scientist and friend this week with the passing of Meri Firpo from metastatic breast cancer. I’m going to post a tribute to Meri from several of us sometime this coming week. I’m in a bit of a somber mood but still trying to write, read, and do all
Weekly stem cell reads: COVID, tail regeneration, aging Read More »
This week marked the release of new draft FDA guidance on cell and gene therapies. Is the FDA kind of like the guidance counselor at school or more like the principal? It probably depends on many factors. I also find it funny how pretty much everyone in academia and biotech industry works to be compliant
Weekly reads: New FDA guidance, brains, MSCs, senescence Read More »
The news of the week relates to an interim clinical trial report from gene-editing firm Editas on its CRISPR trial for a form of vision loss. On to that in a minute. What have you been reading the past week? Below, I include our weekly list of recommended reads. However, first I wanted to give
The Niche weekend reads: Editas mess, The Niche updates, papers Read More »
A piece on human tails and how we lost them caught my eye so I’ll start my weekly reads with that. This week I had the fewest Zoom meetings in ages, which allowed me to get more work done in my own lab and more reading. How about that? I even had some in-person meetings
Recommended reads: a tale of human tails, heart reprogramming, pericytes, microglia Read More »
I’ve been busy recently focusing more on grant and paper writing than reading papers on stem cells, but my piece on trying to de-extinct mammoths via cloning-like methods drew strong opinions on both sides. Recent news and resources on stem cells We’re still awaiting a verdict in the big California federal court case where the FDA is
Weekly reads: news, legos for stem cells, FDA, cancer, more Read More »
Those who follow the stem cell field might be familiar with stem cell clinic operator Neil Riordan. According to a recent press release and some news reports, Riordan just had some bad news in court related to a stem cell clinic in the U.S. Stem cell clinic lawsuit As background, why do those running stem
$7.8 million verdict in stem cell clinics case against Neil Riordan Read More »